Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Thu, 10.10.2024
ABOUT YOU Holding SE
PRESS RELEASE
ABOUT YOU RAISES OUTLOOK FOR ADJUSTED EBITDA IN FY 2024/2025
Revenue grew by 2.4% year-on-year to EUR 450.1 million in Q2 2024/2025 with strong growth of 8.6% in DACH, supported by almost double-digit growth in Germany
Fall/winter season successfully started with double-digit growth rates in September
Adjusted EBITDA1 improved by mo [ … ]
Thu, 10.10.2024
SFC Energy AG
SFC Energy AG and HÖRMANN Warnsysteme present an innovative pilot project for securing the emergency power supply of siren warning systems using fuel cells
Brunnthal/Munich, Germany, 10 October 2024 – SFC Energy AG (“SFC”, F3C:DE, ISIN: DE0007568578), a leading provider of hydrogen and methanol fuel cells for stationary, portable and mobile hybri [ … ]
Thu, 10.10.2024
AGRANA Beteiligungs-Aktiengesellschaft
AGRANA: significant EBIT reduction in first half of 2024|25
Sugar market in particular remains challenging
In the first half of the 2024|25 financial year, AGRANA, the fruit, starch and sugar company, registered a significant year-on-year decrease of 49.0% in operating profit (EBIT) to € 56.6 million. The Group’s revenue eased by 5.0% to € 1,8 [ … ]
Thu, 10.10.2024
Pyrum Innovations AG
Pyrum Innovations AG: First 100% operation in the new plant in Dillingen/Saar successfully completed
First test operation at maximum plant capacity in TAD 3
Oil and gas production reached 95% of planned maximum output
Next MaxCap test with TAD 2 planned in the next two weeks
Dillingen / Saar, 10 October 2024 - Pyrum Innovations AG (“Pyrum”, the [ … ]
Thu, 10.10.2024
Heidelberg Pharma AG
Heidelberg Pharma AG: Interim Management Statement on the First Nine Months of 2024
HDP-101 clinical trial in Europe and US continues with adjusted protocol and dose optimization on track; sixth patient cohort dosed at 90 µg/kg and patients are still on treatment
Sale of a portion of future royalties for TLX250-CDx to HealthCare Royalty
New cli [ … ]
Thu, 10.10.2024
Kuros Biosciences AG
Financial Highlights
Direct MagnetOsTM sales rose by 149% to CHF 50.6 million in the first nine months of 2024, from CHF 20.4 million in the same period in 2023
Total Kuros Medical Devices segment sales accelerated to CHF 51.1 million in Q3 2024 from CHF 21.3 million in Q3 2023 year to date
Kuros Medical Devices segment EBITDA increased to CHF [ … ]
Thu, 10.10.2024
Deutsche Telekom AG
Deutsche Telekom’s Board of Management plans higher dividend for 2024 and buy-backs of Deutsche Telekom shares in 2025
Bonn, October 10, 2024
The Board of Management of Deutsche Telekom AG plans to propose to the annual shareholder meeting to increase the dividend for the 2024 financial year to 0.90 euros per dividend-bearing share, up from 0.77 [ … ]
Wed, 09.10.2024
Laxxon Medical
Laxxon Medical to Attend CPHI Milan 2024, Showcasing the cGMP Printing Technology at Adare Pharma Solution’s Facility in Pessano, Italy New York, 10/09/2024 / 14:01, EST/EDT - EQS Newswire - Laxxon Medical
NEW YORK, NY / ACCESSWIRE / October 9, 2024 / Laxxon Medical, a US-based pharma-technology company pioneering a new generation of adva [ … ]
Wed, 09.10.2024
Flat6Labs
The signing of the memorandum between Bpifrance, Sawari Ventures, and Flat6Labs took place within the framework of the FrancoTech exhibition for Francophonie and Innovation at Station F in Paris, alongside the Francophonie Summit
CAIRO, Egypt, 09 October 2024 – During the FrancoTech exhibition held on October 3 and 4, 2024, at Station F in Pari [ … ]
Wed, 09.10.2024
Lepermislibre
Lepermislibre
/ Key word(s): Quarter Results
Revenue for the third quarter of 2024 09-Oct-2024 / 18:05 CET/CEST
Press release
Revenue for the third quarter of 2024
After a slow quarter, lePERMISLIBRE is preparing for a recovery marked by strategic initiatives.
Lyon, 9th October 2024 – lePERMISLIBRE - ISIN : FR0 [ … ]